Microbiology

  1. Structural basis of a shared antibody response to SARS-CoV-2

    1. Meng Yuan
    2. Hejun Liu
    3. Nicholas C. Wu
    4. Chang-Chun D. Lee
    5. Xueyong Zhu
    6. Fangzhu Zhao
    7. Deli Huang
    8. Wenli Yu
    9. Yuanzi Hua
    10. Henry Tien
    11. Thomas F. Rogers
    12. Elise Landais
    13. Devin Sok
    14. Joseph G. Jardine
    15. Dennis R. Burton
    16. Ian A. Wilson

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  2. Effective Inhibition of SARS-CoV-2 Entry by Heparin and Enoxaparin Derivatives

    1. Ritesh Tandon
    2. Joshua S. Sharp
    3. Fuming Zhang
    4. Vitor H. Pomin
    5. Nicole M. Ashpole
    6. Dipanwita Mitra
    7. Martin G. McCandless
    8. Weihua Jin
    9. Hao Liu
    10. Poonam Sharma
    11. Robert J. Linhardt

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  3. Cross-Sectional Evaluation of Humoral Responses against SARS-CoV-2 Spike

    1. Jérémie Prévost
    2. Romain Gasser
    3. Guillaume Beaudoin-Bussières
    4. Jonathan Richard
    5. Ralf Duerr
    6. Annemarie Laumaea
    7. Sai Priya Anand
    8. Guillaume Goyette
    9. Mehdi Benlarbi
    10. Shilei Ding
    11. Halima Medjahed
    12. Antoine Lewin
    13. Josée Perreault
    14. Tony Tremblay
    15. Gabrielle Gendron-Lepage
    16. Nicolas Gauthier
    17. Marc Carrier
    18. Diane Marcoux
    19. Alain Piché
    20. Myriam Lavoie
    21. Alexandre Benoit
    22. Vilayvong Loungnarath
    23. Gino Brochu
    24. Elie Haddad
    25. Hannah D. Stacey
    26. Matthew S. Miller
    27. Marc Desforges
    28. Pierre J. Talbot
    29. Graham T. Gould Maule
    30. Marceline Côté
    31. Christian Therrien
    32. Bouchra Serhir
    33. Renée Bazin
    34. Michel Roger
    35. Andrés Finzi

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  4. Rapid inactivation of SARS-CoV-2 with Deep-UV LED irradiation

    1. Hiroko Inagaki
    2. Akatsuki Saito
    3. Hironobu Sugiyama
    4. Tamaki Okabayashi
    5. Shouichi Fujimoto

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  5. Identification of unique mutations in SARS-CoV-2 strains isolated from India suggests its attenuated pathotype

    1. Shubham Gaurav
    2. Shambhavi Pandey
    3. Apurvasinh Puvar
    4. Tejas Shah
    5. Madhvi Joshi
    6. Chaitanya Joshi
    7. Sachin Kumar

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  6. Comparative study of four SARS-CoV-2 Nucleic Acid Amplification Test (NAAT) platforms demonstrates that ID NOW performance is impaired substantially by patient and specimen type

    1. Paul R. Lephart
    2. Michael A. Bachman
    3. William LeBar
    4. Scott McClellan
    5. Karen Barron
    6. Lee Schroeder
    7. Duane W. Newton

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  7. An OpenData portal to share COVID-19 drug repurposing data in real time

    1. Kyle R. Brimacombe
    2. Tongan Zhao
    3. Richard T. Eastman
    4. Xin Hu
    5. Ke Wang
    6. Mark Backus
    7. Bolormaa Baljinnyam
    8. Catherine Z. Chen
    9. Lu Chen
    10. Tara Eicher
    11. Marc Ferrer
    12. Ying Fu
    13. Kirill Gorshkov
    14. Hui Guo
    15. Quinlin M. Hanson
    16. Zina Itkin
    17. Stephen C. Kales
    18. Carleen Klumpp-Thomas
    19. Emily M. Lee
    20. Sam Michael
    21. Tim Mierzwa
    22. Andrew Patt
    23. Manisha Pradhan
    24. Alex Renn
    25. Paul Shinn
    26. Jonathan H. Shrimp
    27. Amit Viraktamath
    28. Kelli M. Wilson
    29. Miao Xu
    30. Alexey V. Zakharov
    31. Wei Zhu
    32. Wei Zheng
    33. Anton Simeonov
    34. Ewy A. Mathé
    35. Donald C. Lo
    36. Matthew D. Hall
    37. Min Shen

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  8. Nanozyme chemiluminescence paper test for rapid and sensitive detection of SARS-CoV-2 antigen

    1. Dan Liu
    2. Chenhui Ju
    3. Chao Han
    4. Rui Shi
    5. Xuehui Chen
    6. Demin Duan
    7. Jinghua Yan
    8. Xiyun Yan

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  9. Several FDA-Approved Drugs Effectively Inhibit SARS-CoV-2 Infection in vitro

    1. Hua-Long Xiong
    2. Jia-Li Cao
    3. Chen-Guang Shen
    4. Jian Ma
    5. Xiao-Yang Qiao
    6. Tian-Shu Shi
    7. Sheng-Xiang Ge
    8. Hui-Ming Ye
    9. Jun Zhang
    10. Quan Yuan
    11. Tian-Ying Zhang
    12. Ning-Shao Xia

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  10. SARS-CoV-2 Is Restricted by Zinc Finger Antiviral Protein despite Preadaptation to the Low-CpG Environment in Humans

    1. Rayhane Nchioua
    2. Dorota Kmiec
    3. Janis A. Müller
    4. Carina Conzelmann
    5. Rüdiger Groß
    6. Chad M. Swanson
    7. Stuart J. D. Neil
    8. Steffen Stenger
    9. Daniel Sauter
    10. Jan Münch
    11. Konstantin M. J. Sparrer
    12. Frank Kirchhoff

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity
Previous Page 62 of 254 Next